124 related articles for article (PubMed ID: 24010702)
1. Vector sequences are not detected in tumor tissue from research subjects with ornithine transcarbamylase deficiency who previously received adenovirus gene transfer.
Zhong L; Li S; Li M; Xie J; Zhang Y; Lee B; Batshaw ML; Wilson JM; Gao G
Hum Gene Ther; 2013 Sep; 24(9):814-9. PubMed ID: 24010702
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma in a research subject with ornithine transcarbamylase deficiency.
Wilson JM; Shchelochkov OA; Gallagher RC; Batshaw ML
Mol Genet Metab; 2012 Feb; 105(2):263-5. PubMed ID: 22129577
[TBL] [Abstract][Full Text] [Related]
3. Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver.
Bell P; Moscioni AD; McCarter RJ; Wu D; Gao G; Hoang A; Sanmiguel JC; Sun X; Wivel NA; Raper SE; Furth EE; Batshaw ML; Wilson JM
Mol Ther; 2006 Jul; 14(1):34-44. PubMed ID: 16682254
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of a clinical candidate AAV8 vector for ornithine transcarbamylase (OTC) deficiency reveals functional enzyme from each persisting vector genome.
Wang L; Morizono H; Lin J; Bell P; Jones D; McMenamin D; Yu H; Batshaw ML; Wilson JM
Mol Genet Metab; 2012 Feb; 105(2):203-11. PubMed ID: 22133298
[TBL] [Abstract][Full Text] [Related]
5. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.
Raper SE; Chirmule N; Lee FS; Wivel NA; Bagg A; Gao GP; Wilson JM; Batshaw ML
Mol Genet Metab; 2003; 80(1-2):148-58. PubMed ID: 14567964
[TBL] [Abstract][Full Text] [Related]
6. AAV gene therapy corrects OTC deficiency and prevents liver fibrosis in aged OTC-knock out heterozygous mice.
Wang L; Bell P; Morizono H; He Z; Pumbo E; Yu H; White J; Batshaw ML; Wilson JM
Mol Genet Metab; 2017 Apr; 120(4):299-305. PubMed ID: 28283349
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency.
Raper SE; Yudkoff M; Chirmule N; Gao GP; Nunes F; Haskal ZJ; Furth EE; Propert KJ; Robinson MB; Magosin S; Simoes H; Speicher L; Hughes J; Tazelaar J; Wivel NA; Wilson JM; Batshaw ML
Hum Gene Ther; 2002 Jan; 13(1):163-75. PubMed ID: 11779420
[TBL] [Abstract][Full Text] [Related]
8. Developing adenoviral-mediated in vivo gene therapy for ornithine transcarbamylase deficiency.
Raper SE; Wilson JM; Yudkoff M; Robinson MB; Ye X; Batshaw ML
J Inherit Metab Dis; 1998; 21 Suppl 1():119-37. PubMed ID: 9686350
[TBL] [Abstract][Full Text] [Related]
9. Induction and prevention of severe hyperammonemia in the spfash mouse model of ornithine transcarbamylase deficiency using shRNA and rAAV-mediated gene delivery.
Cunningham SC; Kok CY; Dane AP; Carpenter K; Kizana E; Kuchel PW; Alexander IE
Mol Ther; 2011 May; 19(5):854-9. PubMed ID: 21386824
[TBL] [Abstract][Full Text] [Related]
10. Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors.
Moscioni D; Morizono H; McCarter RJ; Stern A; Cabrera-Luque J; Hoang A; Sanmiguel J; Wu D; Bell P; Gao GP; Raper SE; Wilson JM; Batshaw ML
Mol Ther; 2006 Jul; 14(1):25-33. PubMed ID: 16677864
[TBL] [Abstract][Full Text] [Related]
11. Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter.
Kiwaki K; Kanegae Y; Saito I; Komaki S; Nakamura K; Miyazaki JI; Endo F; Matsuda I
Hum Gene Ther; 1996 May; 7(7):821-30. PubMed ID: 8860834
[TBL] [Abstract][Full Text] [Related]
12. Long-term correction of ornithine transcarbamylase deficiency by WPRE-mediated overexpression using a helper-dependent adenovirus.
Mian A; McCormack WM; Mane V; Kleppe S; Ng P; Finegold M; O'Brien WE; Rodgers JR; Beaudet AL; Lee B
Mol Ther; 2004 Sep; 10(3):492-9. PubMed ID: 15336649
[TBL] [Abstract][Full Text] [Related]
13. An Exon-Specific Small Nuclear U1 RNA (ExSpeU1) Improves Hepatic OTC Expression in a Splicing-Defective
Balestra D; Ferrarese M; Lombardi S; Ziliotto N; Branchini A; Petersen N; Bosma P; Pinotti M; van de Graaf SFJ
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228018
[No Abstract] [Full Text] [Related]
14. [Analysis of ornithine transcarbamylase gene mutations in three boys affected with late-onset ornithine transcarbamylase deficiency].
Chen Z; Wen P; Wang G; Liu X; Chen L; Chen S; Wan L; Cui D; Shang Y; Li C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Oct; 31(5):565-9. PubMed ID: 25297582
[TBL] [Abstract][Full Text] [Related]
15. AAV-encoded OTC activity persisting to adulthood following delivery to newborn spf(ash) mice is insufficient to prevent shRNA-induced hyperammonaemia.
Cunningham SC; Kok CY; Spinoulas A; Carpenter KH; Alexander IE
Gene Ther; 2013 Dec; 20(12):1184-7. PubMed ID: 24108150
[TBL] [Abstract][Full Text] [Related]
16. [Molecular diagnosis of OTC gene mutation in a Chinese family with ornithine transcarbamylase deficiency].
Meng LL; Jiang T; Qin L; Ma DY; Chen YL; Han SP; Yu ZB; Guo XR; Hu P; Xu ZF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):195-8. PubMed ID: 23568734
[TBL] [Abstract][Full Text] [Related]
17. Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency.
Li S; Cai Y; Shi C; Liu M; Liu B; Lin L; Xiao X; Hao H
Med Sci Monit; 2018 Oct; 24():7431-7437. PubMed ID: 30333473
[TBL] [Abstract][Full Text] [Related]
18. Efficient mitochondrial import of newly synthesized ornithine transcarbamylase (OTC) and correction of secondary metabolic alterations in spf(ash) mice following gene therapy of OTC deficiency.
Zimmer KP; Bendiks M; Mori M; Kominami E; Robinson MB; Ye X; Wilson JM
Mol Med; 1999 Apr; 5(4):244-53. PubMed ID: 10448647
[TBL] [Abstract][Full Text] [Related]
19. Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update.
Caldovic L; Abdikarim I; Narain S; Tuchman M; Morizono H
J Genet Genomics; 2015 May; 42(5):181-94. PubMed ID: 26059767
[TBL] [Abstract][Full Text] [Related]
20. Recombinant adeno-associated virus integration sites in murine liver after ornithine transcarbamylase gene correction.
Zhong L; Malani N; Li M; Brady T; Xie J; Bell P; Li S; Jones H; Wilson JM; Flotte TR; Bushman FD; Gao G
Hum Gene Ther; 2013 May; 24(5):520-5. PubMed ID: 23621841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
